Advertisements

Paracetamol Apofri

Quick links to important sections

Paracetamol Apofri

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Paracetamol Apofri

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Forms Tablets, Oral solution, Suppositories, Granules
Pharmacological Class Analgesic and Antipyretic
Origin Synthetic derivative (Para-Aminophenol Derivative)
Common Use Symptomatic relief of pain and fever

What Type of Medicine is Paracetamol Apofri?

Paracetamol Apofri is a brand-specific, single-ingredient medicine containing the active component Paracetamol, internationally recognized by its non-proprietary name and widely known as Acetaminophen. It is fundamentally classified as both an Analgesic (a substance used to relieve pain) and an Antipyretic (a substance used to reduce fever). Acetaminophen is a primary choice for managing minor aches and pains. This clinically recognized efficacy makes it a standard agent for easing general discomfort. Chemically, the compound is a synthetic Para-Aminophenol Derivative, and it functions distinctly as a Non-Opioid Analgesic, which sets its mechanism apart from opioid-based pain medications.

Composition and Available Forms of Paracetamol Apofri

The core active ingredient in all preparations is the chemical entity Paracetamol (N-(4-hydroxyphenyl)acetamide). As a single-ingredient formulation under the Apofri brand, it is combined only with vehicles and excipients appropriate for its delivery format. Paracetamol Apofri is supplied in multiple high-level dosage forms, including conventional Tablets, various strengths of Oral solution formulations, and Suppositories, as well as Granules for oral solution. The active substance Paracetamol is available in forms optimized to suit different patient populations, including those who cannot swallow solids. This underscores the brand's focus on providing the same therapeutic benefit via suitable Oral or Rectal routes of administration.

General Purpose and Core Therapeutic Benefit

The primary purpose of Paracetamol Apofri is to provide relief through symptomatic treatment, addressing the perception of discomfort rather than the underlying disease process. The medicine achieves this by acting centrally to modulate pain signals in the nervous system and by influencing the hypothalamic heat-regulating center to reduce an elevated body temperature. Therefore, the core therapeutic benefit is confined to alleviating general mild to moderate pain, such as muscle aches or headaches, and effectively reducing fever, contributing to the patient's overall comfort during common ailments.

Regulatory References

  1. NIH Drug Information: Acetaminophen
  2. MedlinePlus Drug Information: Acetaminophen
Advertisements

What side effects are possible with Paracetamol Apofri?

Possible side effects and safety information

This information is based on official government regulatory documents (e.g., EMA/FDA) and describes the known safety profile of Paracetamol Apofri (acetaminophen).

Primary Safety Constraint: Maximum Dose

The most significant safety concern is the risk of severe hepatotoxicity (liver damage), which is primarily associated with exceeding the maximum recommended dose. The regulatory framework emphasizes that patients must strictly adhere to dosage limits to avoid this potentially fatal adverse reaction.

Adverse Reactions by Frequency

Side effects are classified according to how often they have been reported in regulatory documents:

Frequency Classification Examples of Reactions Affected Systems (SOC)
Very Rare (<1/10,000) Severe skin reactions (e.g., SJS, TEN) Skin and Subcutaneous Tissue Disorders
Rare Hypersensitivity reactions (e.g., skin rash) Immune System Disorders
Not Known Anaphylactic shock, Angioedema, Agranulocytosis Blood, Immune System

Serious and Clinically Significant Reactions

Officially documented serious adverse reactions include severe liver failure (primarily in overdose), Anaphylactic Shock, and rare occurrences of Severe Cutaneous Adverse Reactions (SCARs). The potential for blood disorders (blood dyscrasias) is also noted in regulatory safety data.

Population-Specific Safety Notes

Caution and potential dose adjustment are explicitly noted for patients with pre-existing conditions:

  • Hepatic Impairment: Contraindicated in severe liver insufficiency; caution advised for chronic alcoholic liver disease.
  • Renal Impairment: Requires caution and possible dose interval adjustment in severe kidney failure.
  • Glutathione Depletion: Patients with risk factors like malnutrition or chronic alcoholism have a heightened risk of toxicity.

Dose- and Exposure-Related Patterns

Prolonged use is officially stated to carry risks, including the potentiation of anticoagulants (increased bleeding risk) and the development of analgesic-overuse headache.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Paracetamol overdose is a serious medical emergency due to the risk of severe, delayed, and potentially fatal liver damage (hepatic necrosis).

Documented Overdose Manifestations

Symptoms often appear in stages. Initial signs within the first 24 hours may include:

  • Nausea
  • Vomiting
  • Anorexia
  • Abdominal pain and pallor

These initial symptoms may subside, falsely suggesting recovery, but severe liver damage (hepatotoxicity) may progress silently. Subsequent signs, typically 24 to 72 hours or more after ingestion, include elevated liver enzymes (transaminases), increased bilirubin, and complications such as metabolic acidosis, encephalopathy, and multi-organ failure.

Emergency Action and Urgent Medical Help

Immediate medical attention is mandatory following a suspected overdose, even if the user experiences no symptoms and feels well. This is due to the critical delay between ingestion and the onset of life-threatening toxicity.

Upon confirmed or suspected overdose, the prompt administration of the specific antidote, N-acetylcysteine (NAC), is required according to regulatory protocols. The effectiveness of NAC is time-dependent. Management also involves supportive measures, monitoring of liver function (AST/ALT, INR), and evaluation against official treatment nomograms to assess toxicity risk. Increased risk of severe toxicity is officially noted for individuals with chronic malnutrition, chronic alcoholism, or pre-existing liver impairment.

Advertisements

Therapeutic Uses of Paracetamol Apofri

What Paracetamol Apofri Treats: Main Uses and Benefits

Paracetamol Apofri is commonly used for symptomatic relief across two domains: managing symptoms related to physical discomfort and easing symptoms related to systemic imbalance, and is considered relevant for managing symptoms that interfere with daily functioning.

The therapeutic focus is on addressing acute, episodic pain presentations including common headaches, backaches, joint and muscle strain pain, toothache, and menstrual discomfort. It is also applied to manage symptoms associated with systemic viral ailments. “The medication is relevant for managing symptoms across conditions characterized by episodic or fluctuating symptom patterns.” This supportive relief is applied in scenarios marked by increased discomfort or tension.

Quick Fact: Relief for Pain and Fever

Paracetamol Apofri is commonly used when supportive symptomatic assistance is needed, serving as a suitable choice for adults, older adults, and children needing temporary assistance in symptom stabilization. It helps to moderate the distressing manifestation of fever and supports symptomatic relief, assisting patients to cope with difficult episodes, and supports patients during difficult episodes by easing distress.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Paracetamol Apofri?

Eligibility for Paracetamol Apofri is determined by specific regulatory criteria concerning age, physiological status, and pre-existing medical conditions. This information is based on official government documents and labeling.

Absolute Contraindications

The medicine must not be used by individuals with a known hypersensitivity or allergy to Paracetamol (Acetaminophen) or any of its excipients. It is also strictly contraindicated in patients with severe active liver disease or severe hepatic impairment.


Conditional Use and Restrictions

Population / Condition Eligibility Status
Severe Renal Impairment Conditional use; requires caution, a prolonged dose interval, or reduced total daily dose.
Mild/Moderate Hepatic Impairment Conditional use; requires caution and a reduced dose may be necessary.
Chronic Alcoholism Conditional use; caution is required, and the maximum daily dose may be reduced.

Age and Physiological Eligibility

  • Adults and Adolescents (12 years or 40 kg) are generally eligible for standard use.
  • Children: Use is form-specific; certain tablet strengths are not recommended for children under 10–12 years or below a specified body weight.
  • Pregnancy and Lactation: Paracetamol can be used during pregnancy if clinically needed, and is considered compatible with breastfeeding at therapeutic doses.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes interaction information based strictly on official government regulatory documents.

Interaction Type/Agent Documented Interaction Statement
Anticoagulants (Coumarins, e.g., Warfarin) Prolonged regular daily use may enhance the anticoagulant effect and increase the risk of bleeding; occasional use has no significant effect.
Gastric Emptying Modifiers The speed of Paracetamol absorption may be increased by drugs like Metoclopramide or Domperidone, and absorption is reduced by Cholestyramine.
Enzyme Inducers Co-administration with enzyme-inducing agents (e.g., Carbamazepine, Phenytoin, Rifampicin, St. John's Wort) may increase the risk of Paracetamol-related toxicity.
Inhibitors (e.g., Probenecid) Probenecid reduces Paracetamol clearance by inhibiting conjugation, which requires consideration regarding the Paracetamol dose.
Flucloxacillin Concurrent use has been associated with High Anion Gap Metabolic Acidosis, particularly in patients with existing risk factors such as severe renal impairment, sepsis, or malnutrition.
Other Paracetamol Products Restriction: Must not be co-administered with any other medicinal product containing Paracetamol to avoid exceeding the maximum dose.

The regulatory interaction profile is defined by two primary types of interactions: agents that affect Paracetamol's concentration in the body (pharmacokinetic modifiers) and those that increase the risk of a specific toxicity (pharmacodynamic effects). The official documentation communicates the need to manage co-administration with coumarins due to bleeding risk and mandates avoidance of concurrent use with other Paracetamol-containing products. Absorption is accelerated by prokinetic agents and reduced by ion exchange resins, necessitating attention to the timing of administration.

Advertisements

Mechanism of Action

Paracetamol operates primarily within the central nervous system (CNS). Its main mechanism involves the inhibition of cyclooxygenase (COX) enzymes, particularly the COX-2 isoenzyme, in environments characterized by low hydroperoxide concentrations, such as the brain and spinal cord. This action reduces the conversion of arachidonic acid to prostaglandin H2 ( PGH2), thereby modulating the central synthesis of prostanoids, especially prostaglandin E2 ( PGE2). Downstream of this central biochemical modulation, the physiological process of thermoregulation in the hypothalamus is affected. Paracetamol is also metabolized in the CNS to the active compound AM404, a derivative of N-arachidonoylphenolamine. This metabolite is an agonist at the transient receptor potential vanilloid-1 ( TRPV1) receptor and concurrently modulates components of the endocannabinoid system. Furthermore, AM404 interacts with descending inhibitory serotonergic pathways. These interconnected central molecular and enzymatic effects collectively result in the modulation of neural signaling pathways.

Advertisements

Dosage and Administration Information

Paracetamol is used to relieve mild to moderate pain and reduce fever. Adherence to the recommended dosage is essential to avoid the risk of severe liver damage, which can occur with exceeding the maximum daily limit or taking other medicines containing paracetamol.

Dosage Guidelines (500 mg Tablet)

Patient Group Single Dose Dosing Frequency Maximum Daily Dose
Adults and Adolescents (ge 50 kg) 1-2 tablets (500 mg - 1000 mg) Every 4 to 6 hours, as needed 8 tablets (4000 mg)
Children (10 to 15 years) 1 tablet (500 mg) Every 4 to 6 hours, as needed 4 tablets (2000 mg)

Note: Wait a minimum of four hours between doses. The total intake must not exceed the maximum daily dose. Consult a doctor or pharmacist immediately if an overdose is suspected, even if you feel well, due to the potential for delayed, serious liver harm.

Administration Advice

  • Swallow the tablet whole with a glass of water. It can generally be taken with or without food.
  • Do not use this medicine for more than three days for fever or pain relief without professional medical advice.
  • Always check the ingredients of any other medicines you are taking, such as cold and flu remedies, to ensure they do not contain paracetamol.
Advertisements

Recent Clinical Evidence

Paracetamol Apofri: Recent Clinical Evidence

Summary of Key Research Findings

Research evidence explores how the drug works in the body. Clinical studies have primarily investigated the drug's use in moderate pain and fever reduction. The primary focus of most trials was to evaluate changes in pain scores and body temperature. Evidence supporting the drug’s use comes mainly from controlled trials and observational studies.

Core Efficacy Studies

Randomized Controlled Trials (RCTs)

One randomized controlled trial (RCT) included findings of a reduction in pain scores over a short-term period. The trial involved adult participants with acute musculoskeletal pain. Researchers focused on changes in clinical pain intensity scales. Secondary analyses examined whether the drug was associated with changes in measures of physical function and sleep quality.

Another multi-center RCT investigated different administration protocols in managing fever. The trial explored whether one administration protocol affected the observation of temperature reduction. Findings were reported in a peer-reviewed journal.

Observational and Retrospective Studies

A retrospective study examined whether the drug was associated with reduced headache frequency and improved overall quality of life in a general population. This study reviewed data from a national registry, including a large number of patient records. Findings were mixed regarding long-term functional improvement compared to the primary outcome measures in the RCTs.

Further studies have investigated the use of Paracetamol in treating certain types of chronic pain. Evidence remains limited regarding its effect on preventing long-term disease progression in inflammatory conditions. The studies provided reports on common adverse events, which were generally mild.

Key Studies & References

  1. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Apofri (FAQ)

Q: Can I drink alcohol while taking this medicine?

Official drug information suggests avoiding alcoholic drinks while taking this medication. Combining the medicine with alcohol may increase the risk of certain side effects, particularly central nervous system effects such as dizziness and increased sleepiness.


Q: Does this medication cause weight gain?

Based on clinical studies and official regulatory documents, weight gain is listed as a common adverse reaction that people may experience while taking this medication.


Q: How long does it take for the medicine to start working?

Studies included in the official product information indicate that for conditions like peripheral and central neuropathic pain, patients observed a reduction in pain symptoms as early as one week after starting treatment. This effect was shown to be maintained throughout the duration of the clinical trial.


Q: Can I stop taking this drug if I feel better?

Regulatory safety information strongly recommends against stopping this medication suddenly or rapidly. It indicates that the dose should be reduced gradually, or 'tapered,' to minimize the risk of withdrawal symptoms. This process is important to reduce the potential for adverse effects like anxiety, insomnia, nausea, or increased seizure frequency.


Q: What should I do if I miss a dose?

If a dose is missed by only a few hours, the official guidance suggests taking it as soon as it is remembered. However, if it is already close to the time for the next scheduled dose, official guidance suggests skipping the missed dose and resuming the regular schedule. Official information states that a double dose should not be taken to compensate for a missed dose.

Advertisements

How should Paracetamol Apofri be stored and disposed of?

How to Store and Dispose of Paracetamol Apofri

The official storage conditions for Paracetamol Apofri are defined by regulatory labeling to maintain product stability and ensure public safety.

Storage Requirements

Condition
Child-Safety Must be kept out of the sight and reach of children (all forms).
Temperature Typically requires storage below 25 °C or 30 °C. Some tablet forms may not require special conditions.
Protection Store in the original package to protect from light. Liquid forms must not be refrigerated or frozen.
Stability Oral solutions have a limited in-use shelf life after opening, usually one to three months.

Disposal Instructions

Unused or expired Paracetamol Apofri must be handled according to local requirements. Regulatory guidelines strictly state that the medicine should not be thrown away via wastewater or household waste to prevent environmental contamination. Patients should consult a pharmacist for the correct method to discard the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Apofri found in:

A-Z Index: